Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00200382
Recruitment Status : Terminated (The study did not achieve the statistical success to continue.)
First Posted : September 20, 2005
Last Update Posted : December 11, 2007
Millennium Pharmaceuticals, Inc.
Information provided by:
Montefiore Medical Center

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Actual Study Completion Date : May 2007